Modified unilateral periureteral injection technique in the treatment of patients with high-grade vesicoureteral reflux: A study of primary findings
Seyed Alaeddin Asgaria,Afshin Safaei-Aslb,Mandana Mansour-Ghanaiea,Seyed Mohammad Asgaria,Asghar Faryabia,Mohammadreza Bazlia,Faezeh Emami Sigaroudib,Seyed Ahmad Naseri Alavic*()
a Urology Research Center, Razi Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran b School of Medicine, Guilan University of Medical Sciences, Rasht, Iran c Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
Objective:Although endoscopic treatment has been used by many pediatric urologists for the treatment of vesicoureteral reflux (VUR), it has no considerable success in high-grade VUR. We aimed to describe the primary outcomes of unilateral periureteral injection technique (PIT), as well as bilateral PIT in high-grade VUR.
Methods:In this prospective study, we examined 92 ureters in 45 boys and 40 girls from February 2010 to May 2018. Bilateral PIT and unilateral PIT were applied in 67 and 25 refluxing units, respectively. In the unilateral PIT, the subureteral injection site was only at the 5- or 7-o'clock position. However, in the bilateral PIT, the subureteral injection sites were at 5- and 7-o'clock position. Pre- and post-operative reflux grades were evaluated by voiding cystourethrography 6 months after surgery.
Results:Seven patients had bilateral reflux. Overall, 75 (81.5%) ureters showed Grade IV VUR, while 17 (18.5%) had primary Grade V VUR. The mean age of the subjects was 39.2 months. In unilateral PIT ureters, VUR was resolved in 23 (92.0%) refluxing units. It was downgraded to Grade III in one ureter (4.0%) and to Grade II in another ureter (4.0%). In addition, in bilateral PIT cases, VUR was resolved in 60 (89.6%) ureters; it downgraded to Grades II and III in 3 (4.5%) and 4 (6.0%) refluxing units, respectively.
Conclusion:Unilateral PIT can be highly effective in the treatment of selected ureters of high-grade VUR. However, further studies are needed to confirm our results.
. [J]. Asian Journal of Urology, 2023, 10(1): 96-100.
Seyed Alaeddin Asgari,Afshin Safaei-Asl,Mandana Mansour-Ghanaie,Seyed Mohammad Asgari,Asghar Faryabi,Mohammadreza Bazli,Faezeh Emami Sigaroudi,Seyed Ahmad Naseri Alavi. Modified unilateral periureteral injection technique in the treatment of patients with high-grade vesicoureteral reflux: A study of primary findings. Asian Journal of Urology, 2023, 10(1): 96-100.
Downgraded to Grade III, n (%) Bilateral PIT (n=67) Unilateral PIT (n=25)
4 (6.0) 1 (4.0)
Sex, n (%)
Boy
45 (52.9)
Girl
40 (47.1)
Laterality, n (%)
Left
33 (38.8)
Right
45 (52.9)
Bilateral
7 (8.2)
Post-surgery complications, n (%)
Fever
2 (2.4)
Dysuria
6 (7.1)
Flank pain
2 (2.4)
[1]
Jacobson SH, Hansson S, Jakobsson B. Vesico-ureteric reflux: occurrence and long-term risks. Acta Paediatr Suppl 1999; 88: 22e30.
doi: 10.1111/j.1651-2227.1999.tb01315.x
[2]
Arlen AM, Garcia-Roig M, Weiss AD, Leong T, Cooper CS, Kirsch AJ. Vesicoureteral reflux index: 2-institution analysis and validation. J Urol 2016; 195:1294e9.
doi: 10.1016/j.juro.2015.03.094
pmid: 25813448
[3]
Zambaiti E, Sergio M, Casuccio A, Salerno S, Cimador M. Intraoperative ultrasound-assisted approach for endoscopic treatment of vesicoureteral reflux in children. J Pediatr Surg 2017; 52:1661e5.
doi: S0022-3468(17)30243-9
pmid: 28442139
[4]
Matouschek E. [Treatment of vesicorenal reflux by transure-thral teflon-injection (author’s transl)]. Urologe A 1981; 20: 263e4. [Article in German].
[5]
Puri P, O’Donnell B. Correction of experimentally produced vesicoureteric reflux in the piglet by intravesical injection of Teflon. Br Med J (Clin Res Ed) 1984; 289:5e7.
pmid: 6428663
[6]
Kobelt G, Canning DA, Hensle TW, L?ckgren G. The cost-effectiveness of endoscopic injection of dex-tranomer/hyaluronic acid copolymer for vesicoureteral reflux. J Urol 2003; 169:1480e5.
doi: 10.1097/01.ju.0000056638.75652.54
[7]
Jodal U, Smellie JM, Lax H, Hoyer PF. Ten-year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Chil-dren. Pediatr Nephrol 2006; 21:785e92.
[8]
Asgari SA, Asl AS, Safarinejad MR, Ghanaei MM. High success rate with new modi?ed endoscopic treatment for high-grade VUR: a pilot study with preliminary report. J Pediatr Urol 2016; 12:100.e1e4. https://doi.org/10.1016/j.jpurol.2015.07.013.
[9]
Lebowitz RL, Olbing H, Parkkulainen KV, Smellie JM, Tammi-nen-M?bius TE. International system of radiographic grading of vesicoureteral reflux. Pediatr Radiol 1985; 15:105e9.
doi: 10.1007/BF02388714
pmid: 3975102
[10]
Farhat W, B?gli DJ, Capolicchio G, O’Reilly S, Merguerian PA, Khoury A, et al. The dysfunctional voiding scoring system: quantitative standardization of dysfunctional voiding symp-toms in children. J Urol 2000; 164:1011e5.
doi: 10.1097/00005392-200009020-00023
pmid: 10958730
[11]
Garcia-Aparicio L, Rovira J, Blazquez-Gomez E, García-García L, Giménez-Llort A, Rodo J, et al. Randomized clinical trial comparing endoscopic treatment with dextranomer hy-aluronic acid copolymer and Cohen’s ureteral reimplantation for vesicoureteral reflux: long-term results. J Pediatr Urol 2013; 9:483e7.
[12]
Elder JS, Diaz M, Caldamone AA, Cendron M, Green?eld S, Hurwitz R, et al. Endoscopic therapy for vesicoureteral reflux: a meta-analysis. I. Reflux resolution and urinary tract infec-tion. J Urol 2006; 175:716e22.
doi: 10.1016/S0022-5347(05)00210-7
pmid: 16407037
[13]
Kirsch AJ, Perez-Bray?eld MR, Scherz HC. Minimally inva-sive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the Children’s Hospitals of Atlanta Experience. J Urol 2003; 170:211e5.
doi: 10.1097/01.ju.0000072523.43060.a0
[14]
Kirsch AJ, Perez-Bray?eld M, Smith EA, Scherz HC. The modi?ed sting procedure to correct vesicoureteral reflux: improved results with submucosal implantation within the intramural ureter. J Urol 2004; 171:2413e6.
doi: 10.1097/01.ju.0000127754.79866.7f
[15]
Gupta A, Snodgrass W. Intra-ori?ce versus hydrodistention implantation technique in dextranomer/hyaluronic acid in-jection for vesicoureteral reflux. J Urol 2008; 180:1589e93.
doi: 10.1016/j.juro.2008.04.073
pmid: 18710753
[16]
Puri P, Pirker M, Mohanan N, Dawrant M, Dass L, Colhoun E. Subureteral dextranomer/hyaluronic acid injection as ?rst line treatment in the management of high-grade vesicoure-teral reflux. J Urol 2006; 176:1856e60.
doi: 10.1016/j.juro.2006.03.124
[17]
Capozza N, Patricolo M, Lais A, Matarazzo E, Caione P. Endo-scopic treatment of vesico-ureteral reflux: twelve years’ experience. Urol Int 2001; 67:228e31.
pmid: 11598451
[18]
Shim JS, Kim JW, Oh MM, Moon du G. Ef?cacy of hydro-distention implantation technique in treating high-grade ves-icoureteral reflux. Korean J Urol 2012; 53:194e9.
doi: 10.4111/kju.2012.53.3.194
[19]
L?ckgren G, Kirsch AJ. Surgery illustrateddsurgical atlas endoscopic treatment of vesicoureteral reflux. BJU Int 2010; 105:1332e47.
doi: 10.1111/j.1464-410X.2010.09325.x
pmid: 20500570
[20]
Routh JC, Reinberg Y. Predicting success in the endoscopic management of pediatric vesicoureteral reflux. Urology 2010; 76:195e8.
doi: 10.1016/j.urology.2009.09.017
pmid: 19931896
[21]
Yucel S, Gupta A, Snodgrass W. Multivariate analysis of factors predicting success with dextranomer/hyaluronic acid injec-tion for vesicoureteral reflux. J Urol 2007; 177:1505e9.
doi: 10.1016/j.juro.2006.11.077
[22]
Watters ST, Sung J, Skoog SJ. Endoscopic treatment for ves-icoureteral reflux: how important is technique? J Pediatr Urol 2013; 9:1192e7.
doi: 10.1016/j.jpurol.2013.05.002
pmid: 23769202
[23]
Kocherov S, Arafeh WA, Zeldin A, Ostrovsky IA, Ioscovich A, Farkas A, et al. Downgrading of high-grade vesicoureteral reflux is a reliable option in the treatment of children with grade IVeV reflux accompanied by breakthrough infections. J Pediatr Urol 2013; 9:212e6.
doi: 10.1016/j.jpurol.2012.02.006
[24]
Higham-Kessler J, Reinert SE, Snodgrass WT, Hensle TW, Koyle MA, Hurwitz RS, et al. A review of failures of endoscopic treatment of vesicoureteral reflux with dextranomer micro-spheres. J Urol 2007; 177:710e5.
doi: 10.1016/j.juro.2006.09.082
pmid: 17222662
[25]
Yurt?u M, Gürbüzer N, Findik S, Avunduk MC, Günel E. Inves-tigation of histopathologic changes in the ureter walls in vesicoureteral reflux. J Pediatr Surg 2009; 44:802e5.
[26]
Molitierno JA, Scherz HC, Kirsch AJ. Endoscopic treatment of vesicoureteral reflux using dextranomer hyaluronic acid copolymer. J Pediatr Urol 2008; 4:221e8.
doi: 10.1016/j.jpurol.2007.11.015
pmid: 18631931
